Earlier in his career and before co-founding the Nova MSC Group, Mr Lai Teik Kin was in involved in implementation of large scale & regional e-government projects. Since 1999, Teik Kin has served as both Executive Director and Chief Executive Officer of novaHEALTH Pte Ltd, a wholly owned subsidiary of the Nova MSC Bhd, spearheading the Groups foray into healthcare industry. 

From 2005-2012, Teik Kin also served as an Independent Non-Executive Director on the Board of MTouche Berhad, a public-listed company in Malaysia which is a forerunner and leader in wireless network technologies, mobile messaging services and interactive media applications.

In 2016, Teik Kin was appointed Business Mentor to the Singapore National Eye Centre (SNEC) Ophthalmic Technologies Incubator to provide business insights and guidance. 

In 2018, Teik Kin spearheaded a spin-off of EyRIS jointly with Singapore Eye Research Institute (SERI) and National University of Singapore-School of Computing (NUS-SoC) to develop and commercialize the artificial intelligence (AI) solutions for the healthcare industry. SELENA+, our first AI solution, performs automated image analysis for eye diseases such diabetes retinopathy with add-on modules for glaucoma and age-related macular degeneration.

Nil

Nil

Nova MSC Berhad
Direct interest: 64,999,883 ordinary shares
Indirect interest:  Nil 

EyRIS Pte Ltd (42%-owned indirect subsidiary)
Direct interest: 19,999 ordinary shares
Direct interest:  Nil